Produkty 115699-92-8

CAS 115699-92-8 występuje w naszej ofercie pod nazwami: Cortisol-9,12,12-d3, >95% (HPLC), Cortisol-9,12,12-d3, 98 atom % D, min 98% Chemical Purity, Hydrocortisone–d3, Hydrocortisone-d3, 98.41%. Oferty producentów: TRC, CDN, GLPBio, MedChemExpress. Dostępne opakowania: 1mg, 2,5mg, 5mg, 0,01g, 0,005g, 1 mg.

Cortisol-9,12,12-d3, >95% (HPLC)
TRC
  • opakowanie: 1mg, 2,5mg, 5mg
  • Warianty: 3
Zobacz produkt
Cortisol-9,12,12-d3, 98 atom % D, min 98% Chemical Purity
CDN
  • opakowanie: 0,01g, 0,005g
  • Warianty: 2
Zobacz produkt
Hydrocortisone–d3
GLPBio
  • opakowanie: 1mg
  • Warianty: 1
od 2857,72
Zobacz produkt
Hydrocortisone-d3, 98.41%
MedChemExpress
  • opakowanie: 1 mg
  • Warianty: 1
od 5014,78
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(8S,9S,10R,11S,13S,14S,17R)-9,12,12-trideuterio-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,11,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-3-one (CAS 115699-92-8) to związek chemiczny o wzorze sumarycznym C21H30O5 i masie molowej 365.5 g/mol. Nazwa systematyczna IUPAC: (8S,9S,10R,11S,13S,14S,17R)-9,12,12-trideuterio-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,11,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-3-one. InChIKey: JYGXADMDTFJGBT-GNVNMZRRSA-N.

Dane identyfikacyjne
Wzór sumarycznyC21H30O5
Masa molowa365.5 g/mol
Nazwa IUPAC(8S,9S,10R,11S,13S,14S,17R)-9,12,12-trideuterio-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,11,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-3-one
InChIKeyJYGXADMDTFJGBT-GNVNMZRRSA-N
SMILES[2H][C@]12[C@@H](CCC3=CC(=O)CC[C@@]31C)[C@@H]4CC[C@@]([C@]4(C([C@@H]2O)([2H])[2H])C)(C(=O)CO)O

Dane obliczone przez PubChem (NCBI)

Synonimy: Hydrocortisone-d3, orb3138627, Hydrocortisone-d3 Solution in Acetonitrile, 10ug/mL, Hydrocortisone-d3 Solution in Acetonitrile, 100ug/mL
Powiązane formy tego związku
(8S,10R,11S,13S)-9,11,12,12-tetradeuterio-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one C21H30O5
(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H30O5
(8S,9S,10R,11R,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H30O5
(8S,9S,10R,11S,13S,14S,17S)-1,2-dideuterio-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H30O5
(8S,9S,10R,11S,13S,14S,17R)-1,2-dideuterio-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H30O5
Izomery (ten sam wzór sumaryczny)
6,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H30O5
(8S,9S,10R,11S,13R,14S,17S)-11-hydroxy-17-(2-hydroxyacetyl)-13-(hydroxymethyl)-10-methyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C21H30O5
3,4-dihydroxy-2-(2-methylbutanoyl)-5-(3-methylbut-2-enyl)-4-(4-methylpent-3-enoyl)cyclopent-2-en-1-one C21H30O5
2-[[(8R,9S,10S,13S,14S,17S)-17-hydroxy-13-methyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-10-yl]methoxy]acetic acid C21H30O5
2-hydroxy-2-[(8S,9S,10R,11S,13S,14S,17S)-11-hydroxy-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]acetic acid C21H30O5
(8S,9S,10R,11S,13S,14S,17R)-17-[(1R)-1,2-dihydroxyethyl]-11,17-dihydroxy-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one C21H30O5
3,5,6-trihydroxy-2-(2-methylbutanoyl)-4,6-bis(3-methylbut-2-enyl)cyclohexa-2,4-dien-1-one C21H30O5